Geninus Inc. (389030.KQ) stock: key figures, P/E, revenue and dividend

Energy · Coal & Consumable Fuels · South Korea

Price
1,199.00 KRW
Market cap
47.23 bn KRW
P/E (2025)
–
P/S (2025)
4.51
Dividend yield
0.00 %
Net margin
-165.72 %
Return on equity (ROE)
-190.88 %
Return on assets (ROA)
-44.15 %

Geninus Inc. financials

Fiscal year20242025
Revenue6.46 bn KRW10.48 bn KRW
Gross profit81.14 m KRW173.02 m KRW
Operating income-12.29 bn KRW-11.67 bn KRW
EBIT-12.12 bn KRW-16.74 bn KRW
Net income-12.27 bn KRW-17.37 bn KRW
Diluted EPS – continuing operations-367.99 KRW-520.90 KRW

Full history since 2018, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Geninus Inc.

GENINUS Inc., a bioinformation analysis company, engages in the research and development, manufacture, and sale of genome analysis solutions in South Korea, the United States, and Asia. It offers tarhet and biomarker discovery; AI digital pathology; single cell analysis; and spatial and in-situ transcriptomics services; and SPACEINSIGHT, a cutting-edge cloud based integrated analysis platform. It serves hospitals, pharmaceutical companies, and researchers. The company was founded in 2018 and is headquartered in Seoul, South Korea.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 30.10.2026. Details in the risk notice.